Personal Injury Lawyer Blog Providing
Info in Miami & Nationwide

"Colson Hicks Eidson is recognized as one of the top litigation firms in the country, handling local, national and international litigation for a wide range of clients." - Chambers USA

Zantac Lawsuits

September 28, 2021
Colson Hicks Eidson

A Zantac lawsuit is a claim arising from a person who took Zantac and ranitidine contaminated with N-nitrosodimethylamine (NDMA) and later developed cancer. The Zantac lawsuit is an active lawsuit. Those filing Zantac lawsuits are seeking compensation from drug manufacturers for the stomach, bladder, and other cancers associated with NDMA, a probable human carcinogen.

If you or a loved one has taken Zantac and been diagnosed with stomach, bladder, or other forms of cancer, contact a lawyer today. If you have sustained an eye injury from taking the drug, our Miami class action and MDL attorneys at Colson Hicks Eidson can help you file a Zantac lawsuit.

Zantac Lawsuit Overview

People who have filed or are filing Zantac lawsuits have claimed the drug manufacturers designed a defective drug and the drug’s label did not properly warn health care providers and patients that the drug could increase the risk of developing cancer.

Manufacturers have issued recalls for Zantac and ranitidine and the FDA ordered manufacturers to stop selling the drug in April 2020 because of NDMA. The FDA has recommended Prilosec and Nexium as alternatives to Zantac.

Valisure’s lab testing found that some Zantac formulas contain more than 3,000,00 ng of NDMA per tablet. The FDA determined that people should not consume more than 96 nanograms of NDMA a day. Further, according to Valisure, Zantac and Ranitidine may actually form NDMA in a person’s stomach.

Defendants in lawsuits include Sanofi-Aventis U.S. LLC, Sanofi US Services Inc., Chattem Inc., Boehringer Ingelheim, Pfizer, and GlaxoSmithKline. The lawsuits claim Zantac’s design is defective because its active ingredient, ranitidine, is an unstable molecule. Arguments from plaintiffs date back to 1981, stating that the defendants failed to warn the public that ranitidine could cause cancer.

Status of Zantac Lawsuit

As of July 15, 2021, there are 670 lawsuits pending in the MDL before Judge L. Rosenberg.  The lawsuits are currently in the initial stages of litigation and discovery has been started and is supposed to be completed by December 2021.

All federal Zantac lawsuits have been consolidated in multidistrict litigation (MDL) in Florida.

Cases against Teva Pharmaceutical and Amneal Pharmaceuticals have been dismissed because federal law prevents them from being sued.

Additionally, to the MDL cases, there are several proposed class action cases filed in New Jersey, California, Florida, Connecticut, and Massachusetts. Anyone who bought Zantac or the generic form, ranitidine, can join the class action—plaintiffs do not need a cancer diagnosis for the class action suit.

Contact Us Today

If you or a loved one has taken Zantac and been diagnosed with stomach, bladder, or other forms of cancer, contact an attorney today. You may be eligible to file a Zantac lawsuit. Our Miami personal injury attorneys at Colson Hicks Eidson can help you today.

When we accept a case, we are committed to pursuing a favorable resolution regardless of the complexity of the case, no matter how long it takes. If you have sustained an injury from Zantac, contact our law firm to ask how one of our class action and MDL attorneys can assist you. We have an office in Florida; however, we handle cases nationwide and internationally. You can contact us by calling us at 305-476-7400.

    ×